XIST and cancer: Loss of XIST can give cancer stem cells the advantage of maintaining their pool of stem-like cancer cells and giving them a proliferative advantage in a cancer context, in which cancer stem cells are defined as subpopulations of cancer cells capable of renewal and differentiation.